Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).
Notes:
Gender:
Countries with data available for the gender: Austria, Belgium, Bulgaria, Czech Republic, Germany, Estonia, Spain, Finland, France, Greece, Hungary, Italy, Lithuania, Luxembourg, Latvia, Malta, The Netherlands, Poland, Slovenia, Slovakia and United Kingdom.
Number of samples: 539 (275 males; 264 females)
Total sample size: 485195
407554 (males); 77641 (females).
Age:
Countries with data available for age: Austria, Belgium, Bulgaria, Czech Republic, Estonia, Spain, Finland, France, Greece, Hungary, Lithuania, Luxembourg, Latvia, Malta, Poland, Portugal, Slovenia, Slovakia, Turkey, United Kingdom.
Number of samples: 425 (155, <25); (137, 25-34); (133, >34).
Total sample size: 141009
27159 (<25); 56235 (25-34); 57615 (>34)
Years of injection:
Countries with data available for years of injection: Austria, Belgium, Spain, France, Greece, Lithuania, Latvia, Poland, Portugal, Slovenia, Turkey, United Kingdom.
Number of samples: 135 (65, <2 years); (70, >2 years)
Total sample size: 22529
2701 (<2 years); 19558 (>2 years)
Primary drug:
Countries with data available for primary drug: Austria, Belgium, Bulgaria, Czech Republic, Germany, Spain, France, Greece, Latvia, Lithuania, Malta, Poland, Portugal, Slovenia, Slovakia, Turkey.
Number of samples: 143 (78 opiates; 65 non-opiates)
Total sample size: 66870
522 (non-opiates); 66348 (opiates)
See also 'General notes for interpreting data' on the Explanatory notes and help page.
Sources:
National Focal Points.